ARTICLE | Distillery Therapeutics
Agonizing adiponectin receptors to treat NASH, liver fibrosis
December 31, 2020 5:23 PM UTC
DISEASE CATEGORY: Hepatic
INDICATION: Non-alcoholic steatohepatitis (NASH); liver fibrosis...
BCIQ Company Profiles
DISEASE CATEGORY: Hepatic
INDICATION: Non-alcoholic steatohepatitis (NASH); liver fibrosis...
BCIQ Company Profiles
BCIQ Company Profiles